This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2008 Nov 5;300(17):2051-3.

doi: 10.1001/jama.2008.510.

Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?

Mark O Goodarzi¹, Bruce M Psaty

Affiliations

Affiliation

¹ Division of Endocrinology, Diabetes and Metabolism, Medical Genetics Institute, Cedars-Sinai Medical Center, and Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

PMID: 18984894
DOI: 10.1001/jama.2008.510

Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?

Mark O Goodarzi et al. JAMA. 2008.

. 2008 Nov 5;300(17):2051-3.

doi: 10.1001/jama.2008.510.

Authors

Mark O Goodarzi¹, Bruce M Psaty

Affiliation

¹ Division of Endocrinology, Diabetes and Metabolism, Medical Genetics Institute, Cedars-Sinai Medical Center, and Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

PMID: 18984894
DOI: 10.1001/jama.2008.510

No abstract available

PubMed Disclaimer

Similar articles

[Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
Hemmingsen B, Lund SS, Vaag A. Hemmingsen B, et al. Ugeskr Laeger. 2009 May 4;171(19):1598-602. Ugeskr Laeger. 2009. PMID: 19419642 Review. Danish.
Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
Bajaj M, Jialal I. Bajaj M, et al. Metab Syndr Relat Disord. 2009 Apr;7(2):79-81. doi: 10.1089/met.2008.0092. Metab Syndr Relat Disord. 2009. PMID: 19351292 No abstract available.
[Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
Sjöholm A. Sjöholm A. Lakartidningen. 2001 Feb 28;98(9):937-40. Lakartidningen. 2001. PMID: 11292972 Review. Swedish.
Glucose control in type 2 diabetes: still worthwhile and worth pursuing.
Kahn SE. Kahn SE. JAMA. 2009 Apr 15;301(15):1590-2. doi: 10.1001/jama.2009.511. JAMA. 2009. PMID: 19366780 No abstract available.
Glycaemic control and macrovascular complications of type 2 diabetes.
Dandona P, Chaudhuri A. Dandona P, et al. Natl Med J India. 2008 Nov-Dec;21(6):271-4. Natl Med J India. 2008. PMID: 19691214 No abstract available.

See all similar articles

Cited by

Endothelial insulin and IGF-1 receptors: when yes means NO.
Muniyappa R, Sowers JR. Muniyappa R, et al. Diabetes. 2012 Sep;61(9):2225-7. doi: 10.2337/db12-0654. Diabetes. 2012. PMID: 22923650 Free PMC article. No abstract available.
Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.
Iyngkaran P, Thomas M, Majoni W, Anavekar NS, Ronco C. Iyngkaran P, et al. Cardiorenal Med. 2012 Dec;2(4):281-297. doi: 10.1159/000342487. Epub 2012 Oct 31. Cardiorenal Med. 2012. PMID: 23381594 Free PMC article.
Acute myocardial infarction associated to DPP-4 inhibitors.
Nunes JP, Rodrigues JD, Melão F. Nunes JP, et al. Heart Lung Vessel. 2014;6(3):180-6. Heart Lung Vessel. 2014. PMID: 25279360 Free PMC article.
Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke: The Framingham Study.
Saber H, Himali JJ, Beiser AS, Shoamanesh A, Pikula A, Roubenoff R, Romero JR, Kase CS, Vasan RS, Seshadri S. Saber H, et al. Stroke. 2017 Jul;48(7):1760-1765. doi: 10.1161/STROKEAHA.116.016563. Epub 2017 Jun 8. Stroke. 2017. PMID: 28596451 Free PMC article.
Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity.
Webb DR, Khunti K, Silverman R, Gray LJ, Srinivasan B, Lacy PS, Williams B, Davies MJ. Webb DR, et al. Diabetologia. 2010 Jun;53(6):1190-8. doi: 10.1007/s00125-010-1689-9. Epub 2010 Mar 6. Diabetologia. 2010. PMID: 20213236

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information